EDITAS MEDICINE, INC. Ttl Prevsly Pd Amt
EDITAS MEDICINE, INC. (EDIT) had Ttl Prevsly Pd Amt of $0 as of 2026-08-28, per its S-3 filed 2026-08-31.
Financial Statements › Notes
ffd:TtlPrevslyPdAmt · last filed 2026-08-31
- 2026-08-28: Ttl Prevsly Pd Amt $0.00.
- 2026-05-26: Ttl Prevsly Pd Amt $0.00.
| Period end | Ttl Prevsly Pd Amt |
|---|---|
| 2026-08-28 | $0.00 S-3 · filed 2026-08-31 |
| 2026-05-26 | $0.00 S-3MEF · filed 2026-05-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |